Cargando…
Withdrawal from Long-Term Use of Unusually High-Dose Oxazepam
Benzodiazepine (BZD) misuse is a worldwide problem that healthcare professionals encounter in daily practice. High-dose BZD withdrawal is usually a long process that may require referral to an inpatient rehabilitation unit. Relapses after withdrawal are common. BZD withdrawal can cause complications...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589494/ https://www.ncbi.nlm.nih.gov/pubmed/34777889 http://dx.doi.org/10.1155/2021/2140723 |
_version_ | 1784598733532430336 |
---|---|
author | Mustonen, Antti Leijala, Juhani Aronranta, Johanna Lassila, Antero Aalto, Mauri Koskimäki, Janne |
author_facet | Mustonen, Antti Leijala, Juhani Aronranta, Johanna Lassila, Antero Aalto, Mauri Koskimäki, Janne |
author_sort | Mustonen, Antti |
collection | PubMed |
description | Benzodiazepine (BZD) misuse is a worldwide problem that healthcare professionals encounter in daily practice. High-dose BZD withdrawal is usually a long process that may require referral to an inpatient rehabilitation unit. Relapses after withdrawal are common. BZD withdrawal can cause complications including seizures, suicidal behavior, anxiety, and depression. Guidelines describe tapering protocols for modest doses; however, protocols for exceptionally high-dose BZD withdrawal are not well described. Herein, we describe a BZD tapering protocol for a patient with daily use of high-dose (1800 mg) oxazepam (OXP). The BZD tapering was administered in an inpatient psychiatric hospital, and the outcome was evaluated monthly after discharge for three months. This report describes a unique case of high-dose OXP withdrawal and also outlines an optional protocol to apply when clinicians encounter these unusual cases. |
format | Online Article Text |
id | pubmed-8589494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-85894942021-11-13 Withdrawal from Long-Term Use of Unusually High-Dose Oxazepam Mustonen, Antti Leijala, Juhani Aronranta, Johanna Lassila, Antero Aalto, Mauri Koskimäki, Janne Case Rep Psychiatry Case Report Benzodiazepine (BZD) misuse is a worldwide problem that healthcare professionals encounter in daily practice. High-dose BZD withdrawal is usually a long process that may require referral to an inpatient rehabilitation unit. Relapses after withdrawal are common. BZD withdrawal can cause complications including seizures, suicidal behavior, anxiety, and depression. Guidelines describe tapering protocols for modest doses; however, protocols for exceptionally high-dose BZD withdrawal are not well described. Herein, we describe a BZD tapering protocol for a patient with daily use of high-dose (1800 mg) oxazepam (OXP). The BZD tapering was administered in an inpatient psychiatric hospital, and the outcome was evaluated monthly after discharge for three months. This report describes a unique case of high-dose OXP withdrawal and also outlines an optional protocol to apply when clinicians encounter these unusual cases. Hindawi 2021-11-05 /pmc/articles/PMC8589494/ /pubmed/34777889 http://dx.doi.org/10.1155/2021/2140723 Text en Copyright © 2021 Antti Mustonen et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Mustonen, Antti Leijala, Juhani Aronranta, Johanna Lassila, Antero Aalto, Mauri Koskimäki, Janne Withdrawal from Long-Term Use of Unusually High-Dose Oxazepam |
title | Withdrawal from Long-Term Use of Unusually High-Dose Oxazepam |
title_full | Withdrawal from Long-Term Use of Unusually High-Dose Oxazepam |
title_fullStr | Withdrawal from Long-Term Use of Unusually High-Dose Oxazepam |
title_full_unstemmed | Withdrawal from Long-Term Use of Unusually High-Dose Oxazepam |
title_short | Withdrawal from Long-Term Use of Unusually High-Dose Oxazepam |
title_sort | withdrawal from long-term use of unusually high-dose oxazepam |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589494/ https://www.ncbi.nlm.nih.gov/pubmed/34777889 http://dx.doi.org/10.1155/2021/2140723 |
work_keys_str_mv | AT mustonenantti withdrawalfromlongtermuseofunusuallyhighdoseoxazepam AT leijalajuhani withdrawalfromlongtermuseofunusuallyhighdoseoxazepam AT aronrantajohanna withdrawalfromlongtermuseofunusuallyhighdoseoxazepam AT lassilaantero withdrawalfromlongtermuseofunusuallyhighdoseoxazepam AT aaltomauri withdrawalfromlongtermuseofunusuallyhighdoseoxazepam AT koskimakijanne withdrawalfromlongtermuseofunusuallyhighdoseoxazepam |